<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0512222977
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2022
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        XROMI
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        HYDROXYCARBAMIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        100
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Oral solution
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        150
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store in a refrigerator (2°c – 8°c)
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        1393.30
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Nova Laboratories Ltd" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Nova Laboratories Ltd
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 461]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            QOMEL MEDICAL DRUG STORE
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Nova Laboratories Limited
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        L01XX05
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Xromi contains hydroxycarbamide, a substance which reduces the growth and multiplication of some cells in the bone marrow. These effects lead to a reduction of circulating red, white and coagulation blood cells. In Sickle Cell Disease, hydroxycarbamide also helps to prevent red blood cells from taking the abnormal sickle shape.</p><p>Sickle Cell disease is an inherited blood disorder that affects the disc shaped red cells of the blood. Some cells become abnormal, rigid and take a crescent or sickle shape which leads to anaemia.</p><p>The sickle cells also get stuck in blood vessels, blocking blood flow. This can cause acute pain crises and organ damage.</p><p>&nbsp;</p><p>Xromi is used to prevent the complications of blocked blood vessels caused by Sickle Cell Disease in patients over 9 months of age. Xromi will decrease the number of painful crises as well as the need for hospitalisation as a result of the disease.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Xromi</strong></p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are allergic to hydroxycarbamide or any of the other ingredients of Xromi (listed in section 6).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you suffer from severe liver disease</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you suffer from severe kidney disease</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have decreased production of red, white, or coagulating blood cells (&lsquo;myelosuppressed&rsquo;) as described in section 3 &ldquo;How to take Xromi, Treatment follow-up&rdquo;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are pregnant or breast-feeding (see section &ldquo;Pregnancy, breast-feeding and fertility&rdquo;)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you take antiretroviral medicines for the treatment of Human Immunodeficiency Virus (HIV), the virus which causes AIDS</p><p>&nbsp;</p><p><strong>Warnings and precautions </strong></p><p><strong>&nbsp;</strong></p><p><strong>Test and checks</strong></p><p><strong>&nbsp;</strong></p><p>Your doctor will run blood tests:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to check your blood count before and during treatment with Xromi</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to monitor your liver before and during treatment with Xromi</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to monitor your kidneys before and during treatment with Xromi</p><p>&nbsp;</p><p>Talk to your doctor, pharmacist or nurse before taking Xromi</p><p><strong>&nbsp;</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have extreme tiredness, weakness and shortness of breath, which may be symptoms of a lack of red blood cells (anaemia)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have bleeding or bruise easily, which may be symptoms of low levels of cells in the blood known as platelets</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have a liver disease (additional monitoring may be needed)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have a kidney disease (the dose may be adjusted)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have leg ulcers</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have a known lack of vitamin B<sub>12</sub> or folate</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have previously received radiotherapy or chemotherapy, or are currently taking any other</p><p>medicines for cancer treatment, especially interferon therapy</p><p>If you are not sure if any of the above applies to you, talk to your doctor or pharmacist before taking</p><p>Xromi.</p><p>&nbsp;</p><p>Talk to your doctor immediately during taking Xromi</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have tiredness, shortness of breath, unexplained bruising or bleeding, which may be symptoms of secondary leukaemia. Secondary leukaemia has been reported in patients receiving long-term hydroxycarbamide for some types of blood cancers (myeloproliferative disorders, such as polycythaemia).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have ulcers, which may be symptoms of cutaneous vasculitic toxicities. Cutaneous vasculitic toxicities are cutaneous lesions that have been reported in patients with some types of blood cancers (myeloproliferative disorders) during therapy with hydroxycarbamide, most often in patients with a history of, or currently receiving interferon therapy.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have suspicious changes in your skin, such as new spots and changes to existing freckles or moles, which may be symptoms of skin cancer. Skin cancer has been reported in patients receiving long term hydroxycarbamide.</p><p>You should protect your skin from the sun and regularly inspect your skin yourself during the treatment and after discontinuation of the therapy with Xromi. Your doctor will also inspect your skin during routine follow-up visits.</p><p>&nbsp;</p><p><strong>Children</strong></p><p><strong>&nbsp;</strong></p><p>Do not give this medicine to children from birth to 9 months of age because it is unlikely to be safe.</p><p>&nbsp;</p><p><strong>Other medicines and Xromi</strong></p><p><strong>&nbsp;</strong></p><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.</p><p>&nbsp;</p><p>In particular, tell your doctor, nurse or pharmacist if you are taking any of the following:</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; other myelosuppressive medicines (those that decrease production of red, white, or coagulating blood cells)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; radiation therapy or chemotherapy</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; any medicines for cancer treatment, especially interferon therapy - when used with Xromi there is a greater chance of side effects, such as anaemia</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; antiretroviral medicines (those that inhibit or destroy a retrovirus such as HIV), e.g. didanosine, stavudine, and indinavir (a drop in your white cell count may occur)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; live vaccines, e.g. measles, mumps, rubella (MMR), chicken pox</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; continuous glucose monitor (CGM), used to test your blood glucose (hydroxycarbamide may falsely elevate sensor glucose results from certain CGM systems and may lead to hypoglycaemia if sensor glucose results are relied upon to dose insulin).</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>Pregnancy, breast-feeding and fertility</strong></p><p><strong>&nbsp;</strong></p><p>Do not take Xromi if you are planning to have a baby without first speaking to your doctor for advice. This applies to both men and women. Xromi may harm your sperm or eggs.</p><p>&nbsp;</p><p>Xromi must not be used during pregnancy. Xromi should be stopped 3 to 6 months prior to becoming pregnant, if possible.</p><p>&nbsp;</p><p>Please contact your doctor immediately if you think you may be pregnant.</p><p>&nbsp;</p><p>You and your partner must use effective contraception methods before, during and after your treatment with Xromi. The use of effective contraception methods must be continued after the end of your treatment with Xromi, for at least 6 months for female and 3 months for male patients.</p><p>&nbsp;</p><p>For male patients taking Xromi, if your partner becomes pregnant or plans to become pregnant, your doctor will discuss with you the potential benefits and risks of continuing using Xromi.</p><p>&nbsp;</p><p>Hydroxycarbamide, the active substance of Xromi, passes into human breast milk. Do not breast-feed while taking Xromi. Ask your doctor or pharmacist for advice.</p><p>&nbsp;</p><p><strong>Driving and using machines</strong></p><p><strong>&nbsp;</strong></p><p>Xromi can make you feel drowsy. You should not drive or operate any machinery unless it has been shown not to affect, you and you have discussed it with your doctor.</p><p>&nbsp;</p><p><strong>Xromi contains methyl parahydroxybenzoate (E218)</strong></p><p><strong>&nbsp;</strong></p><p>Xromi contains methyl parahydroxybenzoate (E218) which may cause allergic reactions (possibly delayed).</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.</p><p>&nbsp;</p><p>Xromi should only be given to you by a specialist doctor who is experienced in treating blood problems.</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; When you take Xromi your doctor will take regular blood tests. This is to check the number and type of cells in your blood and to check your liver and kidney.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Depending on the dose you take, these tests may be performed initially once a month and then every 2-3 months.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Depending on these results your doctor may change your dose of Xromi.</p><p>&nbsp;</p><p>Check with your doctor or pharmacist if you are not sure. The usual starting dose for adults, adolescents and children over the age of 9 months is 15&nbsp;mg/kg each day and the usual maintenance dose is between 20‑25&nbsp;mg/kg. Your doctor will prescribe the correct dose for you. Sometimes the doctor may change your dose of Xromi, for example as a result of different tests. If you are not sure how much medicine to take, always ask your doctor or nurse.</p><p>&nbsp;</p><p><strong>Xromi with food and drink</strong></p><p>You can take this medicine with or after meals at any time of the day. However, the choice of method and time of day should be consistent from day to day.</p><p>&nbsp;</p><p><strong>Use in elderly</strong></p><p>You may be more sensitive to the effects of Xromi and your doctor may need to give you a lower dose.</p><p>&nbsp;</p><p><strong>If you have kidney disease</strong></p><p>Your doctor may need to give you a lower dose.</p><p>You should not take Xromi if you have severe kidney disease.</p><p>&nbsp;</p><p><strong>Handling</strong></p><p>Your pack of Xromi contains a bottle of medicine, a cap, a bottle adaptor and two dosing syringes (a 3&nbsp;ml syringe and a 10&nbsp;ml syringe). Always use the syringes provided to take your medicine.</p><p>&nbsp;</p><p>&nbsp;</p><p><img alt="" width="936" height="605" src="data:image/png;base64,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" /></p><p>&nbsp;</p><p>&nbsp;</p><p>It is important that you use the correct dosing syringe for your medicine. Your doctor or pharmacist will advise which syringe to use depending on the dose that has been prescribed.</p><p>&nbsp;</p><p>The smaller 3&nbsp;ml syringe, marked from 0.5&nbsp;ml to 3&nbsp;ml, is for measuring doses of less than or equal to 3&nbsp;ml. You should use this one if the total amount you have to take is less than or equal to 3&nbsp;ml (each graduation of 0.1&nbsp;ml contains 10&nbsp;mg of hydroxycarbamide).</p><p>The larger 10&nbsp;ml syringe, marked from 1&nbsp;ml to 10&nbsp;ml, is for measuring doses of more than 3&nbsp;ml.</p><p>You should use this one if the total amount you have to take is more than 3&nbsp;ml (each graduation of</p><p>0. 5&nbsp;ml contains 50&nbsp;mg of hydroxycarbamide).</p><p>&nbsp;</p><p>If you are a parent or care giver administering the medicine, wash your hands before and after administering a dose. Wipe up spillages immediately. To decrease the risk of exposure disposable gloves should be used when handling Xromi. To minimise air bubbles, do not shake the bottle before administering a dose.</p><p>&nbsp;</p><p>If Xromi comes into contact with skin, eyes or nose, it should be washed immediately and thoroughly with soap and water.</p><p>&nbsp;</p><p>When you use the medicine follow the instructions below:</p><p>&nbsp;</p><p><img alt="" width="632" height="152" src="data:image/jpeg;base64,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" /></p><p>&nbsp;</p><p>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Put on disposable hand gloves before handling Xromi.</p><p>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Remove the bottle cap <strong>(figure 1)</strong> and push the adaptor firmly into the top of the bottle and leave in place for future doses <strong>(figure 2)</strong>.</p><p>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Push the tip of the dosing syringe into the hole in the adaptor <strong>(figure 3)</strong>. <strong>Your doctor or pharmacist will advise you of the correct syringe to use, either the 3&nbsp;ml or the 10&nbsp;ml syringe in order to give the correct dose</strong>.</p><p>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turn the bottle upside down <strong>(figure 4)</strong>.</p><p>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pull the plunger of the syringe back so that the medicine is drawn from the bottle into the syringe. Pull the plunger back to the point on the scale that corresponds to the dose prescribed <strong>(figure 4)</strong>. If you are not sure about how much medicine to draw into the syringe, always ask your doctor or nurse for advice.</p><p>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turn the bottle back the right way up and carefully remove the syringe from the adaptor, holding it by the barrel rather than the plunger.</p><p>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Gently put the tip of the syringe into your mouth and to the inside of your cheek.</p><p>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Slowly and gently push the plunger down to gently squirt the medicine into the inside of your cheek and swallow it. DO NOT forcefully push down the plunger, or squirt the medicine to the back of your mouth or throat, as you may choke.</p><p>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Remove the syringe from your mouth.</p><p>10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Swallow the dose of oral solution then drink some water, making sure no medicine is left in your mouth.</p><p>11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Put the cap back on the bottle with the adaptor left in place. Ensure that the cap is tightly closed.</p><p>12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Wash the syringe with cold or warm tap water and rinse well. Hold the syringe under water and move the plunger up and down several times to make sure the inside of the syringe is clean. Let the syringe dry completely before you use that syringe again for dosing. Store the syringe in a hygienic place with the medicine.</p><p>&nbsp;</p><p>Repeat the above for each dose as instructed by your doctor or pharmacist.</p><p>&nbsp;</p><p><strong>If you take more Xromi than you should</strong></p><p><strong>&nbsp;</strong></p><p>If you take more Xromi than you should, tell your doctor or go to a hospital immediately. Take the medicine pack and this leaflet with you. The most common symptoms of overdose with Xromi are:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Redness of the skin,</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Soreness (touch is painful) and swelling of the palms of hands and soles of feet followed by the hands and feet becoming scaly,</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Skin becoming strongly pigmented (locally changes of colour),</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Soreness or swelling in the mouth.</p><p>&nbsp;</p><p><strong>If you forget to take Xromi</strong></p><p><strong>&nbsp;</strong></p><p>Tell your doctor. <strong>Do not take a double dose to make up for a forgotten dose.</strong></p><p><strong>&nbsp;</strong></p><p><strong>If you stop taking Xromi</strong></p><p><strong>&nbsp;</strong></p><p>Do not stop taking your medicine unless advised by your doctor. If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p>&nbsp;</p><p><strong>If you get any of the following serious side effects, talk to your doctor or go to hospital immediately:</strong></p><p>&nbsp;</p><p><strong>Very common (may affect more than 1 in 10 people):</strong></p><p><strong>&nbsp;</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A severe infection</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fever or chills</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tiredness and/or looking pale</p><p>&nbsp;</p><p><strong>Common (may affect up to 1 in 10 people):</strong></p><p><strong>&nbsp;</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Unexplained bruising (accumulation of blood under the skin) or bleeding</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sore (open skin infection) on your skin</p><p>&nbsp;</p><p><strong>Uncommon (may affect up to 1 in 100 people):</strong></p><p><strong>&nbsp;</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Any yellowing of the whites of the eyes or skin (jaundice)</p><p>&nbsp;</p><p><strong>Rare (may affect up to 1 in 1000 people):</strong></p><p><strong>&nbsp;</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ulcers or wounds on your legs</p><p>&nbsp;</p><p><strong>Very rare (may affect up to 1 in 10,000 people):</strong></p><p><strong>&nbsp;</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inflammation of the skin causing red scaly patches and possibly occurring together with pain in the joints</p><p>&nbsp;</p><p><strong>Other side effects which are not mentioned above are listed below. Speak to your doctor if you are concerned by any of these side effects.</strong></p><p><strong>&nbsp;</strong></p><p><strong>Very common (may affect more than 1 in 10 people):</strong></p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Absence or low amount of sperm in the semen (azoospermia or oligospermia).</p><p>&nbsp;</p><p><strong>Common (may affect up to 1 in 10 people):</strong></p><p><strong>&nbsp;</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nausea</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Headache</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dizziness</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Constipation</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Darkening of the skin, nails and mouth</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dry skin</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hair loss</p><p>&nbsp;</p><p><strong>Uncommon (may affect up to 1 in 100 people):</strong></p><p><strong>&nbsp;</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Itching red eruption of the skin (rash)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Diarrhoea</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vomiting</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inflammation or ulceration of the mouth</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Elevated liver enzymes</p><p>&nbsp;</p><p><strong>Other side effects (the frequency is not known):</strong></p><p><strong>&nbsp;</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Isolated cases of malignant disease of blood cells (leukaemia)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Skin cancers in elderly patients</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stomach pain or heartburn</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Gastrointestinal ulcer</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fever</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Absence of menstrual cycles (amenorrhoea)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Weight gain</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Low Vitamin D level in blood test</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Low magnesium level in blood test</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bleeding</p><p>&nbsp;</p><p>&nbsp;</p><p>To report any side effect(s):</p><ul><li><strong><em>Saudi Arabia: </em></strong></li></ul><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p><p><strong>- </strong>The National Pharmacovigilance Centre (NPC)</p><ul><li>Toll free phone: 19999</li><li>E-mail: npc.drug@sfda.gov.sa&nbsp;&nbsp;</li><li>Website: https://ade.sfda.gov.sa/</li></ul><p>&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><ul><li>Other GCC States:</li></ul><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Please contact the relevant competent authority.</p><p>&nbsp;</p><p><strong>&nbsp;</strong></p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Keep this medicine out of the sight and reach of children. Accidental ingestion can be lethal for children.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not use this medicine after the expiry date which is stated on the carton and the bottle after &lsquo;EXP&rsquo;. The expiry date refers to the last day of that month.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; After first opening of the bottle, discard any unused contents after 12 weeks.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Store in a refrigerator (2 &deg;C &ndash; 8 &deg;C)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Keep the bottle tightly closed to prevent spoilage of the medicine and reduce the risk of accidental spillage.</p><p>&nbsp;</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is hydroxycarbamide. One ml of solution contains 100&nbsp;mg of hydroxycarbamide.</p><p>&nbsp;</p><p>The other ingredients are xanthan gum, sucralose (E955), strawberry flavour, methyl parahydroxybenzoate (E218), sodium hydroxide, and purified water. See section 2 &ldquo;Xromi contains methyl parahydroxybenzoate&rdquo;.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Xromi is a clear, colourless to pale yellow, oral solution. It comes in glass bottles of 150 ml capped with a child-resistant closure. 

Each pack contains one bottle, a bottle adaptor and two dosing syringes (a syringe graduated to 3 ml and a white syringe graduated to 10 ml).


Your doctor or pharmacist will advise which syringe to use depending on the dose that has been prescribed

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Marketing Authorization Holder and&nbsp;Manufacturer</p><p>&nbsp;</p><p>Nova Laboratories Ireland Limited</p><p>3rd Floor</p><p>Ulysses House</p><p>Foley Street, Dublin 1</p><p>D01 W2T2</p><p>Ireland</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in March 2025
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">يحتوي اكسرومي على هيدروكسي كارباميد وهي مادة تخفض نمو وتكاثر بعض انواع الخلايا في نخاع العظام. وهذه التأثيرات تؤدي إلى تقليل اعداد خلايا الدم الحمراء والبيضاء وخلايا الصفائح الدموية في الدورة الدموية.</p><p dir="RTL">وفي مرض خلايا الدم المنجلية (فقر الدم المنجلي) يساعد هيدروكسي كارباميد ايضا على منع تغير شكل كريات الدم الحمراء الى الشكل المنجلي غير الطبيعي.</p><p dir="RTL">&nbsp;</p><p dir="RTL">مرض فقر الدم المنجلي هو اضطراب دم وراثي يؤثر على خلايا الدم الحمراء الطبيعية التي لها شكل قرص دائري فتصبح بعض الخلايا غير طبيعية وصلبة وتأخذ شكل الهلال أو المنجل مما يؤدي إلى فقر الدم.</p><p dir="RTL">تنحشر الخلايا المنجلية أيضًا وتتجمع في الأوعية الدموية مما يمنع تدفق الدم. وهذا يمكن أن يسبب نوبات ألم حادة وتلف الأعضاء.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يستعمل اكسرومي للوقاية من مضاعفات انسداد الأوعية الدموية التي يسببها مرض فقر الدم المنجلي لدى المرضى الذين تزيد أعمارهم عن تسعة أشهر. ويقلل اكسرومي من عدد الأزمات المؤلمة وكذلك الحاجة إلى التنويم بالمستشفى نتيجة لهذا المرض.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>لا تأخذ اكسرومي في اي من الحالات التالية :</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من حساسية تجاه هيدروكسي كارباميد أو أي من مكونات اكسرومي الأخرى (المدرجة في القسم 6).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مرض كبدي حاد .</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مرض كلوي حاد .</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; إذا كان لديك انخفاض في إنتاج خلايا الدم الحمراء أو البيضاء أو المتخثرة (&quot;كبت نخاع العظم&quot;) كما هو موضح في القسم 3 &quot;كيفية تناول اكسرومي ، متابعة العلاج&quot;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; بالنسبة للمرأة إذا كانت حاملاً أو مرضعة (أنظري قسم &quot;الحمل والإرضاع والخصوبة&quot;).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تتناول الأدوية المضادة للفيروسات لعلاج فيروس نقص المناعة البشرية (HIV) ، وهو الفيروس المسبب لمرض الإيدز .</p><p>&nbsp;</p><p><strong>المحاذير والإحتياطات :</strong></p><p><u>الاختبارات والفحوصات:</u></p><p>سيقوم طبيبك بإجراء تحاليل الدم التالية:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; تحاليل تعداد مكونات الدم قبل وأثناء العلاج بـاكسرومي .</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; تحاليل لمراقبة وظائف الكبد قبل وأثناء العلاج بـاكسرومي .</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; تحاليل لمراقبة وظائف الكلى قبل وأثناء العلاج بـاكسرومي .</p><p dir="RTL">&nbsp;</p><p>تحدث إلى طبيبك أو الصيدلاني أو الممرضة قبل تناول اكسرومي:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;إذا كنت تعاني من تعب شديد وضعف وضيق في التنفس، وقد تكون هذه أعراض نقص خلايا الدم الحمراء (فقر الدم)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من النزيف أو الكدمات بسهولة، وقد تكون هذه أعراض انخفاض مستويات الخلايا في الدم المعروفة باسم الصفائح الدموية</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مرض في الكبد (قد تكون هناك حاجة إلى مراقبة إضافية)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مرض في الكلى (قد يتم تعديل الجرعة)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من تقرحات الساق</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من نقص معروف في فيتامين ب 12 أو حمض الفوليك</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت قد تلقيت سابقًا علاجًا إشعاعيًا أو علاجًا كيميائيًا، أو تتناول حاليًا أي علاج آخر</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; أدوية لعلاج السرطان، وخاصة علاج الإنترفيرون</p><p>&nbsp;</p><p>إذا لم تكن متأكدًا مما إذا كان أي مما سبق ينطبق عليك، فتحدث إلى طبيبك أو الصيدلاني قبل تناول اكسرومي</p><p>&nbsp;</p><p>تحدث إلى طبيبك فورًا أثناء تناول اكسرومي</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من التعب وضيق في التنفس وكدمات غير مبررة أو نزيف، فقد تكون هذه أعراض سرطان الدم الثانوي. تم الإبلاغ عن الإصابة بسرطان الدم الثانوي لدى المرضى الذين يتلقون هيدروكسي كارباميد لفترة طويلة لعلاج بعض أنواع سرطانات الدم (اضطرابات تكاثر نخاع العظم، مثل كثرة كريات الدم الحمراء).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من تقرحات، والتي قد تكون أعراضًا لتسممات الأوعية الدموية الجلدية. التسممات الوعائية الجلدية هي آفات جلدية تم الإبلاغ عنها لدى المرضى الذين يعانون من بعض أنواع سرطانات الدم (اضطرابات تكاثر نخاع العظم) أثناء العلاج بهيدروكسي كارباميد، وغالبًا ما تكون لدى المرضى الذين لديهم تاريخ من العلاج بالإنترفيرون أو يتلقونه حاليًا.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان لديك تغييرات مريبة في بشرتك، مثل بقع جديدة وتغيرات في النمش أو الشامات الموجودة، والتي قد تكون أعراضًا لسرطان الجلد. تم الإبلاغ عن الإصابة بسرطان الجلد لدى المرضى الذين يتلقون هيدروكسي كارباميد لفترة طويلة.</p><p>&nbsp;</p><p>يجب عليك حماية بشرتك من الشمس وفحص بشرتك بانتظام بنفسك أثناء العلاج وبعد التوقف عن العلاج بهيدروكسي كارباميد اكسرومي. سيقوم طبيبك أيضًا بفحص بشرتك أثناء زيارات المتابعة الروتينية.</p><p>&nbsp;</p><p><strong>الأطفال :</strong></p><p>لا تعطي هذا الدواء للأطفال في مرحلة الولادة وحتى عمر تسعة أشهر لأنه من غير المحتمل أن يكون آمنًا.</p><p>&nbsp;</p><p><strong>الأدوية الأخرى واكسرومي :</strong></p><p>أخبر طبيبك أو الصيدلي إذا كنت تتناول أو تناولت مؤخرًا أو قد تتناول أي أدوية أخرى، وعلى وجه الخصوص أخبر طبيبك أو الممرضة أو الصيدلي إذا كنت تتناول أيًا مما يلي:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; أدوية أخرى مثبطة للنخاع العظمي (تلك التي تقلل من إنتاج خلايا الدم الحمراء أو البيضاء أو الصفائح الدموية)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; العلاج الإشعاعي أو العلاج الكيميائي</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; أي أدوية لعلاج السرطان ، وخاصة العلاج بالإنترفيرون - عند استخدامها مع اكسرومي هناك فرصة أكبر لحدوث آثار جانبية ، مثل فقر الدم</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; الأدوية المضادة للفيروسات (تلك التي تثبط أو تدمر الفيروسات مثل فيروس نقص المناعة البشرية) ، على سبيل المثال ديدانوزين وستافودين وإندينافير (قد تسبب انخفاضا في عدد خلايا الدم البيضاء) .</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; لقاحات حية، على سبيل المثال لقاحات الحصبة والنكاف والحصبة الألمانية وجدري الماء.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; الجهاز المستمر لمراقبة الجلوكوز (CGM)، يستخدم لاختبار نسبة الجلوكوز في الدم (قد يؤدي هيدروكسي كارباميد إلى رفع نتائج جلوكوز المستشعر بشكل خاطئ من بعض أنظمة CGM وقد يؤدي إلى نقص سكر الدم إذا تم الاعتماد على نتائج جلوكوز المستشعر لجرعة الأنسولين).</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>الحمل والإرضاع والخصوبة :</strong></p><p>بالنسبة للمرأة يجب أن لا تأخذ اكسرومي إذا كانت تخطط لإنجاب طفل دون التحدث مع طبيبك أولاً للحصول على المشورة. وهذا ينطبق على كل من الرجال والنساء حيث ان اكسرومي قد يؤدي إلى ضرر في الحيوانات المنوية أو البويضات.</p><p>&nbsp;</p><p>لا يجب استخدام اكسرومي أثناء الحمل. ويجب إيقاف اكسرومي قبل 3 إلى 6 أشهر من الحمل إذا أمكن.</p><p>&nbsp;</p><p>بالنسبة للمرأة : يرجى الاتصال بطبيبك على الفور إذا كنت تعتقدين أنك حامل.</p><p>&nbsp;</p><p>يجب عليك أنت وشريكك استخدام وسائل منع الحمل الفعالة قبل وأثناء وبعد العلاج بـ Xromi. يجب الاستمرار في استخدام وسائل منع الحمل الفعالة بعد انتهاء العلاج بـ Xromi، لمدة 6 أشهر على الأقل للمرضى الإناث و3 أشهر للمرضى الذكور.</p><p>&nbsp;</p><p>بالنسبة للمرضى الذكور الذين يتناولون اكسرومي إذا أصبحت شريكتك حاملاً أو كانت تخطط للحمل ، فسوف يناقش طبيبك معك الفوائد والمخاطر المحتملة لاستمرار استخدام اكسرومي.</p><p>&nbsp;</p><p>المادة الفعالة في اكسرومي (هيدروكسي كارباميد) يتم افرازها في حليب الثدي (أثناء الرضاعه). فيجب على المرأة ان لا ترضع أثناء تناول اكسرومي. ويجب التحدث إلى الطبيب أو الصيدلي للحصول على المشورة.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>قيادة السيارات وتشغيل الآليات :</strong></p><p>يمكن أن يسبب اكسرومي الشعور بالنعاس. ويجب ألا تقود السيارة أو تشغل أي آلات إلا إذا ثبت أن تناول هذا الدواء لا تؤثر عليك وناقشت الأمر مع طبيبك.</p><p>&nbsp;</p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>يحتوي اكسرومي على ميثيل باراهيدروكسي بنزوات (</strong><strong>E218</strong><strong>) :</strong></p><p>يحتوي اكسرومي على ميثيل باراهيدروكسي بنزوات (E218) التي قد تسبب تفاعلات تحسسية (ربما يتأخر ظهورها).</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>احرص دائمًا على تناول هذا الدواء تمامًا كما أخبرك طبيبك أو الصيدلي. وعليك استشارة طبيبك أو الصيدلي إذا لم تكن متأكدًا.</p><p>&nbsp;</p><p>لا ينبغي أن يُعطى اكسرومي إلا من قبل طبيب متخصص من ذوي الخبرة في علاج مشاكل الدم.</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; عند تناول اكسرومي سيجري لك الطبيب فحوصات وتحاليل دم منتظمة، وذلك من اجل التحقق من عدد ونوع الخلايا في دمك وفحص وظائف الكبد والكلى.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; اعتمادًا على الجرعة التي تتناولها يمكن إجراء هذه الاختبارات في البداية مرة واحدة شهريًا ثم كل شهرين إلى ثلاثة أشهر.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; بناءً على هذه النتائج ، قد يقوم طبيبك بتغيير جرعتك من اكسرومي.</p><p>&nbsp;</p><p>استشر طبيبك أو الصيدلي إذا لم تكن متأكدًا. الجرعة الاولى المعتادة للبالغين والمراهقين والأطفال الذين تزيد أعمارهم عن 9 أشهر هي 15 ملغم / كغم من وزن الجسم يومياً. والجرعات التالية المعتادة بين 20 - 25 ملغم / كغم من وزن الجسم. سيصف لك طبيبك الجرعة المناسبة لحالتك. وفي بعض الأحيان قد يغير الطبيب جرعتك من اكسرومي، على سبيل المثال بناء على نتائج اختبارات مختلفة. وإذا لم تكن متأكدًا من مقدار الدواء الذي يجب أن تتناوله ، فاسأل طبيبك أو ممرضتك دائمًا.</p><p>&nbsp;</p><p><strong>&nbsp;</strong></p><p><strong>اكسرومي مع الطعام والشراب :</strong></p><p>يمكنك تناول هذا الدواء مع أو بعد الوجبات في أي وقت من اليوم. ومع ذلك ، يجب أن تستمر على أخذ الدواء بنفس الطريقة ونفس الوقت من كل يوم.</p><p>&nbsp;</p><p><strong>الاستخدام لدى كبار السن :</strong></p><p>قد يكون كبار السن أكثر حساسية لتأثيرات اكسرومي وقد يحتاج الطبيب إلى إعطائهم جرعة أقل.</p><p>&nbsp;</p><p><strong>إذا كان لديك مرض في الكلى :</strong></p><p>قد يحتاج طبيبك إلى إعطائك جرعة أقل.</p><p>يجب ألا تتناول اكسرومي إذا كنت تعاني من مرض شديد في الكلى.</p><p>&nbsp;</p><p><strong>التعامل مع الدواء :</strong></p><p>تحتوي عبوة اكسرومي الخاصة بك على زجاجة دواء وغطاء وموالف زجاجة وحقنتين لأخذ الجرعات (حقنة 3 مل وحقنة 10 مل). استخدم دائمًا الحقن المتوفرة لتناول الدواء.</p><p><img alt="" width="936" height="605" src="data:image/jpeg;base64,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" /></p><p>&nbsp;</p><p>من المهم أن تستخدم حقنة الجرعات الصحيحة لدوائك. سينصح طبيبك أو الصيدلي بأي حقنة يجب استخدامها اعتمادًا على الجرعة الموصوفة.</p><p>&nbsp;</p><p>الحقنة الأصغر حجمًا 3 مل، وهي مدرجة من 0.5 مل إلى 3 مل ومخصصة لقياس الجرعات التي تقل عن أو تساوي 3 مل. يجب عليك استخدام هذه الحاقنة إذا كانت الكمية الإجمالية التي يجب أن تأخذها أقل من أو تساوي 3 مل (كل تدريج من 0,1 مل يحتوي على 10 ملغم من هيدروكسي كارباميد).</p><p>&nbsp;</p><p>الحقنة الأكبر حجمًا 10 مل وهي مدرجة من 1 مل إلى 10 مل ومخصصة لقياس الجرعات التي تزيد عن 3 مل.</p><p>يجب عليك استخدام هذه الحاقنة إذا كانت الكمية الإجمالية التي يجب أن تأخذها أكثر من 3 مل (كل تدريج من 0,50 مل يحتوي على 50 ملغ من هيدروكسي كارباميد).</p><p>&nbsp;</p><p>إذا كنت أحد الوالدين أو مقدم الرعاية الذي يشرف على اعطاء الدواء، اغسل يديك قبل وبعد إعطاء الجرعة. امسح الانسكابات على الفور. ولتقليل مخاطر التعرض يجب استخدام القفازات التي تستخدم لمرة واحدة عند التعامل مع اكسرومي. ولتقليل فقاعات الهواء لا ترج الزجاجة قبل إعطاء الجرعة.</p><p>&nbsp;</p><p>إذا لامس اكسرومي الجلد أو العينين أو الأنف ، فيجب غسله فورًا وبالكامل بالماء والصابون.</p><p>&nbsp;</p><p><strong>عند استخدام الدواء ، اتبع التعليمات التالية:</strong></p><p>&nbsp;</p><p><img alt="" width="632" height="152" src="data:image/jpeg;base64,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" /></p><p>&nbsp;</p><p>1.&nbsp;&nbsp;&nbsp;&nbsp; ارتدِ قفازات اليد التي تستخدم لمرة واحدة قبل التعامل مع اكسرومي.</p><p>2.&nbsp;&nbsp;&nbsp;&nbsp; قم بإزالة غطاء الزجاجة (الشكل 1) وادفع الموالف بقوة في الجزء العلوي من الزجاجة واتركه في مكانه للجرعات المستقبلية (الشكل 2).</p><p>3.&nbsp;&nbsp;&nbsp;&nbsp; ادفع طرف حقنة الجرعات في الفتحة الموجودة في الموالف (الشكل 3). وسينصحك طبيبك أو الصيدلي بالحاقنة الصحيحة التي يتوجب عليك استخدامها وهي إما 3 مل&nbsp; أو 10 مل من أجل إعطاء الجرعة الصحيحة.</p><p>4.&nbsp;&nbsp;&nbsp;&nbsp; اقلب الزجاجة رأسًا على عقب (الشكل 4).</p><p>5.&nbsp;&nbsp;&nbsp;&nbsp; اسحب مكبس الحاقنة للخلف بحيث يتم سحب الدواء من الزجاجة إلى الحاقنة. اسحب المكبس إلى النقطة على المقياس التي تتوافق مع الجرعة الموصوفة (الشكل 4).</p><p>وإذا لم تكن متأكدًا من مقدار الدواء الذي يجب سحبه في الحاقنة ، فاطلب دائمًا النصيحة من طبيبك أو ممرضتك.</p><p>6.&nbsp;&nbsp;&nbsp;&nbsp; اقلب الزجاجة إلى الخلف في الاتجاه الصحيح ثم أخرج الحاقنة بحذر من الموالف ، وامسكها من الأسطوانة وليس من المكبس.</p><p>7.&nbsp;&nbsp;&nbsp;&nbsp; ضع طرف الحاقنة برفق في فمك وإلى داخل خدك.</p><p>8.&nbsp;&nbsp;&nbsp;&nbsp; ادفع المكبس ببطء وبلطف لأسفل لبث الدواء برفق داخل فمك وابتلاعه. لا تضغط على المكبس بقوة ، أو ترش الدواء في مؤخرة فمك أو حلقك فقد يسبب لك الاختناق.</p><p>9.&nbsp;&nbsp;&nbsp;&nbsp; قم بإحراج الحاقنة من فمك.</p><p>10. ابتلع جرعة المحلول الفموي ثم اشرب بعض الماء وتأكد من عدم ترك الدواء في فمك.</p><p>11. أعد الغطاء على الزجاجة مع ترك الموالف في مكانه. تأكد من أن الغطاء مغلق بإحكام.</p><p>12. اغسل الحاقنة بماء الصنبور البارد أو الدافئ واشطفها جيدًا. امسك بالحاقنة تحت الماء وحرك المكبس لأعلى ولأسفل عدة مرات للتأكد من نظافة الحاقنة من الداخل. اترك الحاقنة تجف تمامًا قبل استخدامها مرة أخرى للجرعات. احفظ الحاقنة في مكان صحي مع الدواء.</p><p>&nbsp;</p><p>كرر الخطوات السابقة لكل جرعة حسب تعليمات الطبيب أو الصيدلي.</p><p><strong>&nbsp;</strong></p><p><strong>إذا تناولت جرعة من اكسرومي أكثر مما يجب :</strong></p><p>إذا تناولت جرعة اكسرومي أكثر مما هو مقرر لك، أخبر طبيبك أو اذهب إلى المستشفى على الفور. ويجب ان تأخذ علبة الدواء وهذه النشرة معك.</p><p>الأعراض الأكثر شيوعًا للجرعة الزائدة من اكسرومي هي :</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; احمرار الجلد</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; الم عند اللمس(اللمس مؤلم) وانتفاخ راحتي اليدين وباطن القدمين يتبعه تقشر في اليدين والقدمين.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; تصبغ الجلد بقوة (تغيرات محلية في لون الجلد) .</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; ألم أو انتفاخ في الفم.</p><p>&nbsp;</p><p><strong>إذا نسيت تناول اكسرومي :</strong></p><p>أخبر طبيبك. لا تأخذ جرعة مضاعفة لتعويض الجرعة المنسية.</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>إذا توقفت عن تناول اكسرومي :</strong></p><p>لا تتوقف عن تناول هذا الدواء إلا إذا نصحك طبيبك بذلك.</p><p>وإذا كان لديك أي أسئلة أخرى حول استخدام هذا الدواء فعليك أن تسأل الطبيب أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل جميع الأدوية الأخرى يمكن أن يسبب اكسرومي تأثيرات جانبية مع انها لا تحدث لدى جميع من يستخدمون هذا الدواء.</p><p>&nbsp;</p><p>إذا أصبت بأي من الآثار الجانبية الخطيرة التالية يجب عليك التحدث إلى طبيبك أو الذهاب إلى المستشفى على الفور:</p><p>&nbsp;</p><p><strong>&nbsp;</strong></p><p><strong>تأثيرات جانبية شائعة جدًا: قد تظهر لدى أكثر من 1 من بين كل 10 أشخاص :</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp; عدوى شديدة</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; حمى أو قشعريرة</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; التعب و / أو الشحوب</p><p>&nbsp;</p><p><strong>تأثيرات جانبية شائعة: قد تظهر لدى حتى 1 من بين كل 10 أشخاص :</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp; كدمات غير مبررة (تراكم الدم تحت الجلد) أو نزيف</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; بقع التهاب على الجلد (عدوى مكشوفة بالجلد)</p><p>&nbsp;</p><p><strong>تأثيرات جانبية غير شائعة: قد تظهر لدى حتى 1 من بين كل 100 شخص :</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp; أي اصفرار في بياض العينين أو الجلد (اليرقان).</p><p>&nbsp;</p><p><strong>تأثيرات جانبية نادرة: قد تظهر لدى حتى 1 من كل 1000 شخص :</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp; تقرحات أو جروح في الساقين .</p><p>&nbsp;</p><p><strong>تأثيرات جانبية نادرة جدًا: قد تظهر لدى حتى 1 من بين 10000 شخص :</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp; التهاب الجلد الذي قد يسبب ظهور بقع حمراء متقشرة وربما يصاحبه ألم في المفاصل .</p><p>&nbsp;</p><p><strong>التأثيرات الجانبية الأخرى التي لم يتم ذكرها أعلاه مذكورة أدناه. تحدث إلى طبيبك إذا كنت قلقًا من أي من هذه الآثار الجانبية.</strong></p><p>&nbsp;</p><p><strong>تأثيرات جانبية شائعة جدًا: قد تظهر لدى أكثر من 1 من كل 10 أشخاص :</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp; نقص أو انخفاض كمية الحيوانات المنوية في السائل المنوي (فقد النطاف أو قلة النطاف).</p><p>&nbsp;</p><p><strong>&nbsp;</strong></p><p><strong>تأثيرات جانبية شائعة: قد تظهر لدى حتى 1 من كل 10 أشخاص :</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp; غثيان</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; صداع</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; دوار</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; إمساك</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; سواد الجلد والأظافر والفم</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; جفاف البشرة</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; تساقط الشعر</p><p>&nbsp;</p><p><strong>تأثيرات جانبية غير شائعة: قد تظهر لدى حتى 1 من كل 100 شخص</strong> :</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; حكة مع احمرار وطفح بالجلد (طفح جلدي)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; إسهال</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; قيء</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; التهاب أو تقرح في الفم</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; ارتفاع إنزيمات الكبد</p><p>&nbsp;</p><p><strong>أعراض جانبية أخرى (شيوعها غير معروف) :</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp; حالات منعزلة من مرض خبيث لخلايا الدم (ابيضاض الدم او اللوكيميا)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; سرطانات الجلد لدى كبار السن</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; آلام في المعدة أو حرقة في المعدة</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; قرحة الجهاز الهضمى</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; حمى</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; غياب الدورة الشهرية (انقطاع الطمث) لدى النساء</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; زيادة الوزن</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; انخفاض مستوى فيتامين &quot;د&quot; في تحليل الدم</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; انخفاض مستوى المغنيسيوم في تحليل الدم</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نزيف</p><p>&nbsp;</p><p dir="RTL">للإبلاغ عن أي أثر (آثار) جانبية او اية مشكلات تتعلق بالجودة:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المملكه العربيه السعوديه</p><p dir="RTL">&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المركز الوطني للتيقظ والسلامة الدوائية:</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp; فاكس: ٧٦٦٢-٢٠٥-١١-٩٦٦+</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp; الرقم المجاني : 19999</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp; البريد الإلكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp; الموقع الإلكتروني: https://ade.sfda.gov.sa/</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p></td></tr></tbody></table><p dir="RTL">&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; دول مجلس التعاون الخليجي الاخرى</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يرجى الاتصال بالجهة المختصة ذات الصله</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; احفظ هذا الدواء بعيدًا عن أنظار ومتناول الأطفال. ويمكن أن يكون ابتلاع هذا الدواء مميتًا للأطفال .</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية المدون على العلبة والزجاجة &quot;EXP&quot;. ويشير تاريخ انتهاء الصلاحية إلى اليوم الأخير من الشهر المذكور.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بعد فتح الزجاجة لأول مرة يجب التخلص من أي محتويات غير مستخدمة بعد 12 أسبوعًا من فتحها .</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحفظ فى الثلاجة تحت درجة حرارة (2&ordm; - 8&ordm; درجة مئوية) .</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; احفظ الزجاجة مغلقة بإحكام لمنع تلف الدواء وتقليل مخاطر الانسكاب العرضي .</p><p>&nbsp;</p><p>لا تتخلص من الأدوية في مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد تستخدمها. وهذه الإجراءات ستساعد في حماية البيئة .</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>المادة الفعالة هي هيدروكسي كارباميد . يحتوي مل واحد من المحلول على 100 ملغم من هيدروكسي كارباميد .</p><p>&nbsp;</p><p>المكونات الأخرى هي صمغ الزانثان والسكرالوز (E955) ونكهة الفراولة وميثيل باراهيدروكسي بنزوات (E218) وهيدروكسيد الصوديوم والماء النقية.</p><p>انظر القسم 2 تحت عنوان &quot;يحتوي اكسرومي على ميثيل باراهيدروكسي بنزوات&quot;.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>اكسرومي هو محلول رائق شفاف، عديم اللون إلى أصفر باهت. ويقدم في عبوات زجاجية سعة 150 مل مغطاة بإغلاق مقاوم للأطفال. وتحتوي كل عبوة على زجاجة واحدة وموالف زجاجة وحقنتين للجرعات (حقنة مدرجة إلى 3 مل وحقنة مدرجة إلى 10 مل).</p><p>&nbsp;</p><p>سوف ينصح طبيبك أو الصيدلي بأي حاقنة يجب استخدامها اعتمادًا على الجرعة الموصوفة لك .</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p><strong>حامل رخصة التسويق والشركة المصنعه</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">نوفا لابوراتوريز ليمتد</p><p dir="RTL">مارتن هاوس ، جلوستر كريسنت</p><p dir="RTL">ويجستون ، ليستر</p><p dir="RTL">18 جنيه 4YL</p><p dir="RTL">المملكة المتحدة</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            ھ. تمت اخر مراجعه للنشره في شهر مارس 2025
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Xromi 100 mg/ml oral solution
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                One ml of solution contains 100 mg hydroxycarbamide.

Excipients with known effect
One ml of solution contains 0.5 mg methyl hydroxybenzoate.

For the full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Oral solution.
Clear, colorless to pale yellow viscous liquid

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Xromi is indicated for the prevention of vaso-occlusive complications of sickle cell disease in patients over 9 months of age.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Hydroxycarbamide treatment should be supervised by a physician or other healthcare professionals experienced in the management of patients with Sickle Cell Disease.</p><p>&nbsp;</p><p><u>Posology</u></p><p>The posology should be based on the patient&rsquo;s body weight (kg).</p><p>The usual starting dose of hydroxycarbamide is 15&nbsp;mg/kg/day and the usual maintenance dose is between 20-25&nbsp;mg/kg/day. The maximum dose is 35&nbsp;mg/kg/day. Full blood cell count with white cell differential and reticulocyte count should be monitored once a month for the first 2&nbsp;months following treatment initiation.</p><p>A target absolute neutrophil count 1,500&nbsp;&ndash;&nbsp;4,000&nbsp;/&nbsp;&mu;L should be aimed for, whilst maintaining platelet count &gt;&nbsp;80,000/&nbsp;&mu;L. If neutropenia or thrombocytopenia occurs, hydroxycarbamide dosing should be temporarily withheld and full blood cell count with white cell differential should be monitored weekly. When blood counts have recovered, hydroxycarbamide should be reinstated at a dose 5&nbsp;mg/kg/day lower than the dose given before onset of cytopenias.</p><p>If dose escalation is warranted based on clinical and laboratory findings, the following steps should be taken:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dose to be increased by 5&nbsp;mg/kg/day increments every 8 weeks.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increases in dose to be continued until mild myelosuppression (absolute neutrophil count1,500/ &mu;L to 4,000/ &mu;L) is achieved, up to a maximum of 35&nbsp;mg/kg/day.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Full blood cell count with white cell differential and reticulocyte count to be monitored at least every 4 weeks when adjusting dosage.</p><p>Once a maximum tolerated dose is established, laboratory safety monitoring should include full blood cell count with white cell differential, reticulocyte count, and platelet count every 2‑3 months.</p><p>Red blood cell (RBC), mean cell volume (MCV), and foetal haemoglobin (HbF) levels should be monitored for evidence of consistent or progressive laboratory response. However, a lack of increase in MCV, HbF, or both, is not an indication to discontinue therapy if the patient responds clinically (e.g. decreased incidence of pain or hospitalisation).</p><p>A clinical response to treatment with hydroxycarbamide may take 3‑6&nbsp;months and therefore, a 6&nbsp;month trial on the maximum tolerated dose is required prior to considering discontinuation due to treatment failure (whether due to lack of adherence or failure to respond to therapy).</p><p><u>&nbsp;</u></p><p><u>Special populations</u></p><p>&nbsp;</p><p><em>Elderly</em></p><p>Elderly patients may be more sensitive to the myelosuppressive effects of hydroxycarbamide, and may require a lower dosage regimen.</p><p>&nbsp;</p><p><em>Renal impairment</em></p><p>Since renal excretion is a pathway of elimination, consideration should be given to decreasing the dosage of hydroxycarbamide in renally impaired patients. In patients with a creatinine clearance (CrCl)&nbsp;&le;&nbsp;60&nbsp;ml/min the initial hydroxycarbamide dose should be decreased by 50%. Close monitoring of blood parameters is advised in these patients (see section 4.4).</p><p>Hydroxycarbamide must not be administered to patients with severe renal impairment (CrCl&nbsp;&lt;&nbsp;30&nbsp;ml/min) (see sections 4.3, 4.4, and 5.2).</p><p>&nbsp;</p><p><em>&nbsp;</em></p><p><em>&nbsp;</em></p><p><em>Hepatic impairment</em></p><p>There are no data that support specific dose adjustments in patients with hepatic impairment. Close monitoring of blood parameters is advised in these patients. Due to safety considerations, hydroxycarbamide is contraindicated in patients with severe hepatic impairment (see sections 4.3 and 4.4).</p><p>&nbsp;</p><p><em>Children less than &nbsp;9 months of age</em></p><p>The safety and efficacy of hydroxycarbamide in children from birth up to 9 months of age have not yet been established.</p><p>&nbsp;</p><p><u>Method of administration</u></p><p>Xromi is for oral use.</p><p>Two dosing syringes (a 3&nbsp;ml and a 10&nbsp;ml) are provided for accurate measurement of the prescribed dose of the oral solution. It is recommended that the healthcare professional advises the patient or carer which syringe to use to ensure that the correct volume is administered.</p><p>The smaller 3&nbsp;ml syringe, marked from 0.5&nbsp;ml to 3&nbsp;ml, is for measuring doses of less than or equal to 3&nbsp;ml. This syringe should be recommended for doses less than or equal to 3&nbsp;ml (each graduation of 0.1&nbsp;ml contains 10&nbsp;mg of hydroxycarbamide).</p><p>The larger 10&nbsp;ml syringe, marked from 1&nbsp;ml to 10&nbsp;ml, is for measuring doses of more than 3&nbsp;ml. This syringe should be recommended for doses greater than 3&nbsp;ml (each graduation of 0.5&nbsp;ml contains 50&nbsp;mg of hydroxycarbamide).</p><p>In adults without swallowing difficulties, solid oral formulations may be more appropriate and convenient.</p><p>Xromi may be taken with or after meals at any time of the day but patients should standardise the method of administration and time of day.</p><p>To assist accurate and consistent dose delivery to the stomach water should be taken after each dose of Xromi.</p><p dir="rtl">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Severe hepatic impairment (Child-Pugh classification C).
Severe renal impairment (CrCl < 30 ml/min).
Toxic ranges of myelosuppression as described in section 4.2.
Breast-feeding (see section 4.6).
Pregnancy (see section 4.6)
Concomitant anti-retroviral medicinal products for HIV disease (see sections 4.4 and 4.5)

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Bone marrow suppression</u></p><p>The complete status of the blood, including bone marrow examination, if indicated, as well as kidney function and liver function should be determined prior to, and repeatedly during, treatment. If bone marrow function is depressed, treatment with hydroxycarbamide should not be initiated.</p><p>The full blood cell count with white cell differential, reticulate count, and platelet count should be monitored regularly (see section 4.2).</p><p>Hydroxycarbamide may produce bone marrow suppression; leukopenia is generally its first and most common manifestation. Thrombocytopenia and anaemia occur less often and are seldom seen without a preceding leukopenia. Bone marrow depression is more likely in patients who have previously received radiotherapy or cytotoxic cancer chemotherapeutic medicinal products; hydroxycarbamide should be used cautiously in such patients. The recovery from myelosuppression is rapid when hydroxycarbamide therapy is interrupted.</p><p>Hydroxycarbamide therapy can then be re-initiated at a lower dose (see section 4.2).</p><p>&nbsp;</p><p>Severe anaemia must be corrected with whole blood replacement before initiating therapy with hydroxycarbamide. If, during treatment, anaemia occurs, correct without interrupting hydroxycarbamide therapy. Erythrocytic abnormalities; megaloblastic erythropoiesis, which is self- limiting, is often seen early in the course of hydroxycarbamide therapy. The morphologic change resembles pernicious anaemia, but is not related to vitamin B<sub>12</sub> or folic acid deficiency. The macrocytosis may mask the incidental development of folic acid deficiency; regular determinations of serum folic acid are recommended. Hydroxycarbamide may also delay plasma iron clearance and reduce the rate of iron utilisation by erythrocytes but it does not appear to alter the red blood cell survival time.</p><p>&nbsp;</p><p><u>Other</u></p><p>Patients who have received irradiation therapy in the past may have an exacerbation of post irradiation erythema when hydroxycarbamide is given.</p><p>&nbsp;</p><p><u>Renal and hepatic impairment</u></p><p>Hydroxycarbamide should be used with caution in patients with marked renal dysfunction. Hydroxycarbamide may cause hepatotoxicity and liver function tests should be monitored during treatment.</p><p>Blood parameters for renal and hepatic impairment should be closely monitored, and hydroxycarbamide should be discontinued if necessary. If appropriate, hydroxycarbamide should be re-started at a lower dose.</p><p>&nbsp;</p><p><u>HIV patients</u></p><p>Hydroxycarbamide must not be used in combination with anti-retroviral medicinal products for HIV disease and it may cause treatment failure and toxicities (in some cases fatal) in HIV patients (see sections 4.3 and 4.5).</p><p>&nbsp;</p><p><u>Secondary leukaemia and skin cancer</u></p><p>In patients receiving long-term therapy with hydroxycarbamide for myeloproliferative disorders, such as polycythemia, secondary leukaemia has been reported. It is unknown whether this leukaemogenic effect is secondary to hydroxycarbamide or associated with the patient&#39;s underlying disease. Skin cancer has been reported in patients receiving long-term hydroxycarbamide. Patients should be advised to protect skin from sun exposure. In addition patients should conduct self-inspection of the skin during the treatment and after discontinuation of the therapy with hydroxycarbamide and be screened for secondary malignancies during routine follow-up visits.</p><p>&nbsp;</p><p><u>Cutaneous vasculitic toxicities</u></p><p>Cutaneous vasculitic toxicities including vasculitic ulcerations and gangrene have occurred in patients with myeloproliferative disorders during therapy with hydroxycarbamide. The risk of vasculitic toxicities is increased in patients who receive prior or concomitant interferon therapy. The digital distribution of these vasculitic ulcerations and progressive clinical behaviour of peripheral vasculitic insufficiency leading to digital infarct or gangrene were distinctly different than the typical skin ulcers generally described with Hydroxycarbamide. Due to potentially severe clinical outcomes for the cutaneous vasculitic ulcers reported in patients with myeloproliferative disease, hydroxycarbamide should be discontinued if cutaneous vasculitic ulcerations develop.</p><p>&nbsp;</p><p><u>Vaccinations</u></p><p>Concomitant use of hydroxycarbamide with a live virus vaccine may potentiate the replication of the vaccine virus and/or may increase some of the adverse reactions of the vaccine virus because normal defence mechanisms may be suppressed by hydroxycarbamide. Vaccination with a live vaccine in a patient taking hydroxycarbamide may result in severe infection. The patient&#39;s antibody response to vaccines may be decreased. The use of live vaccines should be avoided during treatment and for at least six months after treatment has finished and individual specialist advice sought (see section 4.5).</p><p>&nbsp;</p><p><u>Leg ulcers</u></p><p>In patients with leg ulcers, hydroxycarbamide should be used with caution. Leg ulcers are a common complication of Sickle Cell Disease, but have also been reported in patients treated with hydroxycarbamide.</p><p>&nbsp;</p><p><u>Carcinogenicity</u></p><p>Hydroxycarbamide is unequivocally genotoxic in a wide range of test systems. Hydroxycarbamide is presumed to be a transspecies carcinogen (see section 5.3).</p><p>&nbsp;</p><p><u>Safe handling of the solution</u></p><p>Parents and care givers should avoid hydroxycarbamide contact with skin or mucous membrane. If the solution comes into contact with skin or mucosa, it should be washed immediately and thoroughly with soap and water (see section 6.6).</p><p>&nbsp;</p><p><u>Excipients</u></p><p>This medicinal product contains methyl parahydroxybenzoate (E218) which may cause allergic reactions (possibly delayed).</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The myelosuppressive activity may be potentiated by previous or concomitant radiotherapy or cytotoxic therapy.</p><p>Concurrent use of hydroxycarbamide and other myelosuppressive medicinal products or radiation therapy may increase bone marrow depression, gastro-intestinal disturbances or mucositis. An erythema caused by radiation therapy may be aggravated by hydroxycarbamide.</p><p>Patients must not be treated with hydroxycarbamide and anti-retroviral medicinal products concurrently (see sections 4.3 and 4.4).</p><p>Fatal and non-fatal pancreatitis has occurred in HIV-infected patients during therapy with hydroxycarbamide and didanosine, with or without stavudine.</p><p>Hepatotoxicity and hepatic failure resulting in death were reported during post-marketing surveillance in HIV-infected patients treated with hydroxycarbamide and other antiretroviral medicinal products. Fatal hepatic events were reported most often in patients treated with the combination of hydroxycarbamide, didanosine, and stavudine.</p><p>Peripheral neuropathy, which was severe in some cases, has been reported in HIV-infected patients receiving hydroxycarbamide in combination with anti-retroviral medicinal products, including didanosine, with or without stavudine (see section 4.4).</p><p>&nbsp;</p><p>Patients treated with hydroxycarbamide in combination with didanosine, stavudine, and indinavir showed a median decline in CD4 cells of approximately 100/mm<sup>3</sup>.</p><p>&nbsp;</p><p>Studies have shown that there is an analytical interference of hydroxycarbamide with the enzymes (urease, uricase, and lactic dehydrogenase) used in the determination of urea, uric acid, and lactic acid, rendering falsely elevated results of these in patients treated with hydroxycarbamide.</p><p>&nbsp;</p><p><em>Vaccinations</em></p><p>There is an increased risk of severe or fatal infections with the concomitant use of live vaccines. Live vaccines are not recommended in immunosuppressed patients.</p><p>Concomitant use of hydroxycarbamide with a live virus vaccine may potentiate the replication of the vaccine virus and/or may increase the adverse reaction of the vaccine virus, because normal defence mechanisms may be suppressed by hydroxycarbamide therapy. Vaccination with a live vaccine in a patient taking hydroxycarbamide may result in severe infections. Generally, the patient&#39;s antibody response to vaccines may be decreased. Treatment with hydroxycarbamide and concomitant immunisation with live virus vaccines should only be performed if benefits clearly outweigh potential risks (see section 4.4).</p><p>&nbsp;</p><p>Cutaneous vasculitic toxicities, including vasculitic ulcerations and gangrene, have occurred in patients with myeloproliferative disorders during therapy with hydroxycarbamide. These vasculitic toxicities were reported most often in patients with a history of, or currently receiving, interferon therapy (see section 4.4).</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Women of childbearing potential/Contraception in males and females</u></p><p>Medicinal products which affect DNA synthesis, such as hydroxycarbamide, may be potent mutagenic active substances. This possibility should be carefully considered before administering this medicinal product to male or female patients who may contemplate conception.</p><p>Both male and female patients should be advised to use contraceptive measures before and during treatment with hydroxycarbamide.</p><p>&nbsp;</p><p><u>Pregnancy</u></p><p>Studies in animals have shown reproductive toxicity (see section 5.3). Patients on hydroxycarbamide should be made aware of the risks to the foetus.</p><p>There is limited amount of data from the use of hydroxycarbamide in pregnant women.</p><p>Hydroxycarbamide can cause foetal harm when administered to a pregnant woman. Therefore it must not be administered to patients who are pregnant.</p><p>Patients on hydroxycarbamide wishing to conceive should stop treatment 3 to 6 months before pregnancy if possible.</p><p>The patient should be instructed to immediately contact a doctor in case of suspected pregnancy.</p><p>&nbsp;</p><p><u>Breast-feeding</u></p><p>Hydroxycarbamide is excreted in human breast milk. Because of the potential for serious adverse reactions in breast-feeding infants, breast-feeding must be discontinued while taking hydroxycarbamide.</p><p>&nbsp;</p><p><u>Fertility</u></p><p>Fertility in males might be affected by treatment. Very common reversible oligo- and azoo-spermia have been observed in man, although these disorders are also associated with the underlying disease. Impaired fertility has been observed in male rats (see section 5.3).</p><p>Male patients should be informed by their healthcare professionals about the possibility of sperm conservation (cryopreservation) before the start of therapy.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Hydroxycarbamide has minor influence on the ability to drive and use machines. Patients should be advised not to drive or operate machines, if dizziness is experienced while taking hydroxycarbamide.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The safety profile of hydroxycarbamide in sickle cell disease was established from clinical studies and confirmed with long-term cohort studies including up to 1935 adults and children of more than 9 months of age.</p><p>&nbsp;</p><p><u>Summary of the safety profile</u></p><p>Bone-marrow suppression is the major toxic effect of hydroxycarbamide and is dose related. At lower doses, mild, transient and reversible cytopenias are commonly reported in Sickle Cell Disease patients which is expected based on the pharmacology of hydroxycarbamide.</p><p>Hydroxycarbamide affects spermatogenesis, and hence oligospermia and azoospermia are very commonly reported.</p><p>Other commonly reported adverse effects also include nausea, constipation, headache, and dizziness. Adverse reactions affecting the skin and subcutaneous tissue such as darkening of the skin nail beds, dry skin, skin ulcers, and alopecia tend to occur following several years of long-term daily maintenance therapy. Rarely leg ulcers and very rarely systemic lupus erythematosus have been reported.</p><p>There is also a serious risk of leukaemia and in the elderly, skin cancer, although the frequency is not known.</p><p>&nbsp;</p><p><u>Tabulated list of adverse reactions</u></p><p>The list is presented by system organ class, MedDRA preferred term, and frequency using the following frequency categories: very common (&ge;&nbsp;1/10), common (&ge;&nbsp;1/100 to &lt;&nbsp;1/10), uncommon (&ge;&nbsp;1/1&nbsp;000 to &lt;&nbsp;1/100), rare (&ge;&nbsp;1/10&nbsp;000 to &lt;&nbsp;1/1&nbsp;000), very rare (&lt;&nbsp;1/10&nbsp;000), and not known (cannot be estimated from the available data).</p><p><em>Table 1: Adverse reactions</em></p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0" style="width:521px"><tbody><tr><td><p><strong>System organ class</strong></p></td><td><p><strong>Frequency</strong></p></td><td><p><strong>Adverse reaction</strong></p></td></tr><tr><td><p>Neoplasms benign, malignant and unspecified (including cysts and polyps)</p></td><td><p>Not known</p></td><td><p>Leukaemia, skin cancers (in elderly patients)</p></td></tr><tr><td rowspan="2"><p>Blood and lymphatic system disorders</p></td><td><p>Very common</p></td><td><p>Bone marrow depression including neutropenia (&lt;&nbsp;1,500&nbsp;/&nbsp;&mu;L), reticulocytopenia (&lt;&nbsp;80,000&nbsp;/&nbsp;&mu;L), macrocytosis</p></td></tr><tr><td><p>Common</p></td><td><p>Thrombocytopenia (&lt;&nbsp;80,000&nbsp;/&nbsp;&mu;L), anaemia (haemoglobin &lt;&nbsp;4.5&nbsp;g/dl)</p></td></tr><tr><td><p>Metabolism and nutrition disorders</p></td><td><p>Not known</p></td><td><p>Weight gain, vitamin D deficiency</p></td></tr><tr><td><p>Nervous system disorders</p></td><td><p>Common</p></td><td><p>Headache, dizziness</p></td></tr><tr><td><p>Vascular disorders</p></td><td><p>Not known</p></td><td><p>Bleeding</p></td></tr><tr><td rowspan="3"><p>Gastrointestinal disorders</p></td><td><p>Common</p></td><td><p>Nausea, constipation</p></td></tr><tr><td><p>Uncommon</p></td><td><p>Stomatitis, diarrhoea, vomiting</p></td></tr><tr><td><p>Not known</p></td><td><p>Gastrointestinal disturbances, gastrointestinal ulcer, severe hypomagnesaemia</p></td></tr><tr><td><p>Hepatobiliary disorders</p></td><td><p>Uncommon</p></td><td><p>Elevated liver enzymes, Hepatotoxicity</p></td></tr><tr><td rowspan="4"><p>Skin and subcutaneous tissue disorders</p></td><td><p>Common</p></td><td><p>Skin ulcer, oral, nail and skin hyperpigmentation, dry skin, alopecia</p></td></tr><tr><td><p>Uncommon</p></td><td><p>Rash</p></td></tr><tr><td><p>Rare</p></td><td><p>Leg ulcers</p></td></tr><tr><td><p>Very Rare</p></td><td><p>Systemic and cutaneous lupus erythematosus</p></td></tr><tr><td rowspan="2"><p>Reproductive system and breast disorders</p></td><td><p>Very common</p></td><td><p>Oligospermia, azoospermia</p></td></tr><tr><td><p>Not known</p></td><td><p>Amenorrhea</p></td></tr><tr><td><p>General disorders and administration site conditions</p></td><td><p>Not known</p></td><td><p>Fever</p></td></tr></tbody></table><p>&nbsp;</p><p><u>Description of selected adverse reactions</u></p><p>In the event of bone marrow suppression, haematological recovery usually occurs within two weeks of withdrawal of hydroxycarbamide. Gradual dose titration is recommended to avoid more severe bone marrow suppressions (see section 4.2).</p><p>The macrocytosis caused by hydroxycarbamide is not vitamin B<sub>12</sub> or folic acid dependent. The anaemia commonly observed has mainly been due to an infection with Parvovirus, splenic or hepatic sequestration, renal impairment.</p><p>Weight gain observed during treatment with hydroxycarbamide may be an effect of improved general conditions.</p><p>Oligospermia and azoospermia caused by hydroxycarbamide are in general reversible, but have to be taken into account when fatherhood is desired (see section 5.3). These disorders are also associated with the underlying disease.</p><p><u>Paediatric population</u></p><p>Frequency, type and severity of adverse reactions in children are expected to be similar to adults.</p><p>Data from an observational study (ESCORT-HU) of hydroxycarbamide in a large set of patients (n&nbsp;=&nbsp;1&nbsp;906) with sickle cell disease showed that patients aged 2 to 10 years were at higher risk for neutropenia and at lower risk for dry skin, alopecia, headache and anaemia. Patients aged 10 to 18&nbsp;years were at lower risk for dry skin, skin ulcer, alopecia, weight increase and anaemia compared to adults.</p><p>&nbsp;</p><p>Safety data in children under the age of 2&nbsp;years is limited. The BABY HUG trial, a phase III double-blinded, multi-centre, randomised, controlled study in infants aged 9&nbsp;&ndash;&nbsp;18 months, compared fixed moderate dose hydroxycarbamide at 20&nbsp;mg/kg/day with placebo (Wang et al. 2011). Mild-to-moderate neutropenia (absolute neutrophil count [ANC] 500&ndash;1249/&nbsp;&mu;L), occurred more frequently in the hydroxycarbamide group; 107 times in 45 participants versus 34 times in 18 participants in the placebo group. Recurrent or persistent neutropenia resulted in nine long-term dose decreases (to 17&middot;5&nbsp;mg/kg per day) in the hydroxycarbamide group and five in the placebo group (p&nbsp;=&nbsp;0&middot;20). Infants treated with hydroxycarbamide did not have significant differences from those treated with placebo in rates of severe neutropenia (ANC&nbsp;&lt;&nbsp;500/&nbsp;&micro;L), thrombocytopenia (platelet count &lt;&nbsp;80,000/&nbsp;&micro;L), anaemia (haemoglobin&nbsp; &lt;7&nbsp;g/dL), reticulocytopenia (absolute reticulocyte count&nbsp; &lt;&nbsp;80,000/&nbsp;&micro;L), or abnormal tests of liver function (alanine aminotransferase&nbsp; &gt;150&nbsp;units/L or bilirubin&nbsp;&gt;&nbsp;10&nbsp;mg/dL).</p><p>&nbsp;</p><p>The safety of Xromi has been assessed in 32 children aged 9 months&nbsp;-&nbsp;18 years with sickle cell anaemia in a single-arm, open-label, prospective, multi-center, pharmacokinetic, safety and efficacy study (HUPK study). The total number of hydroxycarbamide-related adverse events was 28 (8.3%) in 9 (28%) patients. Haematological toxicity dominated with 21 reports (75%) of cytopenias and then skin and subcutaneous disorders (5 reports; 18%). The 9 months to 2 year age group had 19 related events (29.2%), a higher proportion compared to the 2 to 6 year group (5 events; 3.4% ) and 6 to 16 year group (4 events; 3.2%). The reported cytopenias were typically isolated, transient and benign.</p><p>&nbsp;</p><p>The long-term safety of hydroxycarbamide initiated in children less than 2 years remains to be established.</p><p><u>&nbsp;</u></p><p>To report any side effect(s):</p><p>&middot;&nbsp;&nbsp; <strong><em>Saudi Arabia: </em></strong></p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p><p><strong>- </strong>The National Pharmacovigilance Centre (NPC)</p><p>o Toll free phone: 19999</p><p>o E-mail: npc.drug@sfda.gov.sa&nbsp;&nbsp;</p><p>o Website: https://ade.sfda.gov.sa/</p><p>&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><p>&middot;&nbsp;&nbsp; Other GCC States:</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp; Please contact the relevant competent authority.</p><p dir="rtl">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Symptoms</u></p><p>Acute mucocutaneous toxicity has been reported in patients receiving hydroxycarbamide at a dosage several times greater than that recommended. Soreness, violet erythema, oedema on palms and foot soles followed by scaling of hands and feet, intense generalised hyperpigmentation of skin, and severe acute stomatitis were observed.</p><p>In patients with sickle cell disease, severe bone marrow depression was reported in isolated cases of hydroxycarbamide overdose between 2 and 10 times the prescribed dose (up to 8.57 times of the maximum recommended dose of 35 mg/kg/day). It is recommended that blood counts are monitored for several weeks after overdose since recovery may be delayed.</p><p>&nbsp;</p><p><u>Treatment</u></p><p>Immediate treatment consists of gastric lavage, followed by supportive therapy for the cardiorespiratory systems if required. Patients should be monitored for vital signs, blood and urine chemistry, renal and hepatic function and full blood counts for at least 3&nbsp;weeks. Longer periods of monitoring may be required. If necessary, blood should be transfused.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Antineoplastic agents, other antineoplastic agents, ATC code: L01XX05.</p><p>&nbsp;</p><p><u>Mechanism of action</u></p><p>Hydroxycarbamide is an orally active antineoplastic agent.</p><p>Although the mechanism of action has not yet been clearly defined, hydroxycarbamide appears to act by interfering with synthesis of DNA by acting as a ribonucleotide reductase inhibitor, without interfering with the synthesis of ribonucleic acid or protein.</p><p>&nbsp;</p><p>One of the mechanisms by which hydroxycarbamide acts is the elevation of HbF concentrations in Sickle Cell Disease patients. HbF interferes with the polymerisation of HbS (sickle haemoglobin) and thus impedes the sickling of red blood cell. In all clinical studies, there was a significant increase in HbF from baseline after hydroxycarbamide use.</p><p>Recently, hydroxycarbamide has shown to be associated with the generation of nitric oxide suggesting that nitric oxide stimulates cyclic guanosine monophosphatase (cGMP) production, which then activates a protein kinase and increases the production of HbF. Other known pharmacological effects of hydroxycarbamide which may contribute to its beneficial effects in Sickle Cell Disease include decrease of neutrophils, improved deformability of sickled cells, and altered adhesion of red blood cells to the endothelium.</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p><u>Clinical efficacy and safety</u></p><p>Evidence for the efficacy of hydroxycarbamide in reducing the vaso-occlusive complications of Sickle Cell Disease in children older than &nbsp;9 months comes from five randomised controlled studies (Charache <em>et al</em> 1995 [MSH Study]; Jain <em>et al</em> 2012, Ferster <em>et al</em> 1996; Ware <em>et al</em> 2015 [TWiTCH], Wang et al 2011 [BABY HUG]). Furthermore, findings from these pivotal studies are supported by observational studies including some long-term follow up.</p><p><em>Multi-centre study of hydroxycarbamide in Sickle Cell Anaemia (MSH)</em></p><p>The MSH study was a multicentre, randomised, and double-blind study, which compared hydroxycarbamide with placebo in adults with Sickle Cell Anaemia (HbSS genotype only) with the objective of reducing the frequency of pain crises. A total of 299 participants were randomised; 152 to hydroxycarbamide and 147 to matching placebo. Hydroxycarbamide was started at low dose (15&nbsp;mg/kg per day) and increased at 12-weekly intervals by 5&nbsp;mg/kg per day until mild bone marrow depression was achieved, as judged by either neutropenia or thrombocytopenia. Once the blood count had recovered, treatment was restarted at 2.5&nbsp;mg/kg per day less than the toxic dose.</p><p>There was a statistically significant difference between the hydroxycarbamide group and placebo group in the mean annual crisis rate (all crises), mean difference -2.80 (95% CI&nbsp; -4.74 to&nbsp; -0.86) (p&nbsp;=&nbsp;0.005), and for crises requiring hospitalisation, mean difference -1.50 (95% CI&nbsp; -2.58 to&nbsp; -0.42) (p&nbsp;=&nbsp;0.007).</p><p>The study also showed an increase in median time from the initiation of treatment to first painful crisis (2.76&nbsp;months in the hydroxycarbamide arm compared with 1.35&nbsp;months on placebo (p&nbsp;=&nbsp;0.014), second painful crisis (6.58&nbsp;months in the hydroxycarbamide group compared with 4.13 months on placebo (p&nbsp;&lt;&nbsp;0.0024), and third painful crisis (11.9 months in the hydroxycarbamide group compared with 7.04&nbsp;months on placebo (p&nbsp;=&nbsp;0.0002).</p><p>Also rates of acute chest syndrome were decreased in those taking hydroxycarbamide when compared with those taking placebo; RR&nbsp;0.44 (95% CI 0.28 to 0.68) (p&nbsp;&lt;&nbsp;0.001). Similar decreases were seen in blood transfusion rates, a surrogate for life-threatening illness. Hydroxycarbamide did not reduce rates of hepatic or splenic sequestration when compared with placebo.</p><p>In keeping with the mechanism of action of hydroxycarbamide, the MSH study also showed a statistically significant increase in HbF (mean difference 3.9% (95% CI 2.69 to 5.11 (p&nbsp;&lt;&nbsp;0.0001)) and haemoglobin levels (mean difference 0.6&nbsp;g/dL (95% CI 0.28 to 0.92, p&nbsp;&lt;&nbsp;0.0014) and a decrease in haemolytic markers in the groups treated with hydroxycarbamide. The MSH study showed increased haematological toxicity resulting in a dose reduction in the hydroxycarbamide group as compared with placebo, but there were no infections related to neutropenia or bleeding episodes due to thrombocytopenia.</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p><u>Paediatric population</u></p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p><em>Cross-over comparison with placebo (Ferster et al 1996)</em></p><p>A randomized cross-over study was conducted in 25 children and young adults (age range: 2 to 22&nbsp;years) with homozygous sickle cell anaemia and severe clinical manifestations (defined as &gt;&nbsp;3 vaso- occlusive crises in the year before study entry and/or with previous history of stroke, acute chest syndrome, recurrent crises without a free interval, or splenic sequestration). The primary outcome measure of the study was the number and duration of hospitalisations. Patients were randomly assigned to receive either hydroxycarbamide first for 6 months, followed by placebo for 6&nbsp;months, or placebo first, followed by hydroxycarbamide for 6&nbsp;months. Hydroxycarbamide was administered at an initial dose of 20&nbsp;mg/kg/day. The dose was increased to 25&nbsp;mg/kg per day if change in HbF was &lt;&nbsp;2% after 2&nbsp;months. Dose was reduced by 50% for bone marrow toxicity.</p><p>The study reported 16 patients out of 22 (73%) did not require any hospitalisation for painful episodes when treated with hydroxycarbamide as compared with only 3 of 22 (14%) when treated with placebo. In addition, there was a reduction in mean hospital stay; 5.3 days in the hydroxycarbamide group and 15.2 days in the placebo group. There were no deaths reported in the study. An increase in HbF and a decrease in absolute neutrophil count were reported in the hydroxycarbamide group. Similarly after six months of treatment, haemoglobin and MCV increased significantly whilst platelet count and white blood cells (WBC) decreased significantly in the hydroxycarbamide group. Results of this study are presented in Tables 2 and 3 below.</p><p>&nbsp;</p><p>Table 2: Number of hospitalisations and number of days in hospital by treatment (both periods combined) (Ferster et al, 1996)</p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0" style="width:463px"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p><strong>Hydroxycarbamide (n=22)</strong></p></td><td style="vertical-align:top"><p><strong>Placebo<br />(n=22)</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Number of hospitalisations</strong></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong>0</strong></p></td><td style="vertical-align:top"><p>16</p></td><td style="vertical-align:top"><p>3</p></td></tr><tr><td style="vertical-align:top"><p><strong>1</strong></p></td><td style="vertical-align:top"><p>2</p></td><td style="vertical-align:top"><p>13</p></td></tr><tr><td style="vertical-align:top"><p><strong>2</strong></p></td><td style="vertical-align:top"><p>3</p></td><td style="vertical-align:top"><p>2</p></td></tr><tr><td style="vertical-align:top"><p><strong>3</strong></p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>3</p></td></tr><tr><td style="vertical-align:top"><p><strong>4</strong></p></td><td style="vertical-align:top"><p>1</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td style="vertical-align:top"><p><strong>5</strong></p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>1</p></td></tr><tr><td style="vertical-align:top"><p><strong>Number of days in hospital</strong></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong>0</strong></p></td><td style="vertical-align:top"><p>16</p></td><td style="vertical-align:top"><p>3</p></td></tr><tr><td style="vertical-align:top"><p><strong>1 &ndash; 10</strong></p></td><td style="vertical-align:top"><p>2</p></td><td style="vertical-align:top"><p>13</p></td></tr><tr><td style="vertical-align:top"><p><strong>&gt;10</strong></p></td><td style="vertical-align:top"><p>4</p></td><td style="vertical-align:top"><p>6</p></td></tr><tr><td style="vertical-align:top"><p><strong>Range</strong></p></td><td style="vertical-align:top"><p>0-19</p></td><td style="vertical-align:top"><p>0-104</p></td></tr></tbody></table><p>&nbsp;</p><p><em>&nbsp;</em></p><p><em>&nbsp;</em></p><p><em>&nbsp;</em></p><p><em>&nbsp;</em></p><p><em>&nbsp;</em></p><p><em>Table 3: Mean haematologic values before and after 6 months of treatment with hydroxycarbamide (Ferster et al, 1996)</em></p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0" style="width:485px"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p><strong>Before Hydroxycarbamide therapy (mean&nbsp;&plusmn;&nbsp;SD)</strong></p></td><td style="vertical-align:top"><p><strong>After Hydroxycarbamide therapy (mean&nbsp;&plusmn;&nbsp;SD)</strong></p></td><td style="vertical-align:top"><p><br /><strong>P value</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Haemoglobin (Hb) (g/dL)</strong></p></td><td style="vertical-align:top"><p>8.1 &plusmn; 0.75</p></td><td style="vertical-align:top"><p>8.5 &plusmn; 0.83</p></td><td style="vertical-align:top"><p>Not significant</p></td></tr><tr><td style="vertical-align:top"><p><strong>MCV (fL)</strong></p></td><td style="vertical-align:top"><p>85.2 &plusmn; 9.74</p></td><td style="vertical-align:top"><p>95.5 &plusmn; 11.57</p></td><td style="vertical-align:top"><p>&lt;0.001</p></td></tr><tr><td style="vertical-align:top"><p><strong>Mean corpuscular haemoglobin concentration<br />(MCHC) (%)</strong></p></td><td style="vertical-align:top"><p>33.0 &plusmn; 2.08</p></td><td style="vertical-align:top"><p>32.3 &plusmn; 1.12</p></td><td style="vertical-align:top"><p>Not significant</p></td></tr><tr><td style="vertical-align:top"><p><strong>Platelets (&times;10<sup>9</sup>/L)</strong></p></td><td style="vertical-align:top"><p>443.2 &plusmn; 189.1</p></td><td style="vertical-align:top"><p>386.7 &plusmn; 144.6</p></td><td style="vertical-align:top"><p>Not significant</p></td></tr><tr><td style="vertical-align:top"><p><strong>WBC (&times;10<sup>9</sup>/L)</strong></p></td><td style="vertical-align:top"><p>12.47 &plusmn; 4.58</p></td><td style="vertical-align:top"><p>8.9 &plusmn; 2.51</p></td><td style="vertical-align:top"><p>&lt;0.001</p></td></tr><tr><td style="vertical-align:top"><p><strong>HbF (%)</strong></p></td><td style="vertical-align:top"><p>4.65 &plusmn; 4.81</p></td><td style="vertical-align:top"><p>15.34 &plusmn; 11.3</p></td><td style="vertical-align:top"><p>&lt;0.001</p></td></tr><tr><td style="vertical-align:top"><p><strong>Reticulocytes (%)</strong></p></td><td style="vertical-align:top"><p>148.6 &plusmn; 53.8</p></td><td style="vertical-align:top"><p>102.7 &plusmn; 48.5</p></td><td style="vertical-align:top"><p>&lt;0.001</p></td></tr></tbody></table><p>&nbsp;</p><p><em>Low fixed dose hydroxycarbamide in children with Sickle Cell Disease (Jain et al 2012)</em></p><p>In a randomised, double-blind, placebo controlled study conducted in a tertiary hospital in India, 60&nbsp;children (aged 5‑18&nbsp;years) with three or more blood transfusions or vaso-occlusive crises requiring hospitalisation per year, were randomised to fixed dose 10&nbsp;mg/mg per day hydroxycarbamide (n&nbsp;=&nbsp;30) or to a matched placebo (n&nbsp;=&nbsp;30). The primary outcome was the decrease in the frequency of vaso‑occlusive crises per patient per year. Secondary outcomes included the decrease in frequency of blood transfusions and hospitalizations, and increase in HbF levels.</p><p>&nbsp;</p><p>After 18 months of treatment, there was a significant difference in the number of vaso-occlusive crises between the hydroxycarbamide group and placebo group, mean difference ‑9.60&nbsp;(95% CI&nbsp;‑10.86 to&nbsp;‑8.34) (p&nbsp;&lt;&nbsp;0.00001). There was also significant difference between the hydroxycarbamide group and placebo groups in the number of blood transfusions, mean difference ‑1.85 (95% CI&nbsp;‑2.18&nbsp;to&nbsp;‑1.52) (p&nbsp;&lt;&nbsp;0.00001), in the number of hospitalisations, mean difference ‑8.89 (95% CI ‑10.04&nbsp;to&nbsp;‑7.74) (p&nbsp;&lt;&nbsp;0.00001), and the duration of hospitalisation, mean difference ‑4.00 days (95% CI ‑4.87&nbsp;to&nbsp;‑3.13) (p&nbsp;&lt;&nbsp;0.00001). Results are presented in Table 4.</p><p>&nbsp;</p><p>The study also showed a statistically significant increase in HbF and Hb levels and a decrease in haemolytic markers in the groups treated with hydroxycarbamide.</p><p>&nbsp;</p><p><em>Table 4: Comparison of the number of clinical events before and after intervention in the Hydroxycarbamide and placebo groups</em></p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td colspan="2" style="vertical-align:top"><p><strong>Hydroxycarbamide</strong></p></td><td colspan="2" style="vertical-align:top"><p><strong>Placebo</strong></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td><p><strong>Number of events / patient / year</strong></p></td><td><p>Before</p></td><td><p>After 18 months</p></td><td><p>Before</p></td><td><p>After 18 months</p></td><td><p>P value<sup>1</sup></p></td><td><p>P value<sup>2</sup></p></td></tr><tr><td style="vertical-align:top"><p><strong>Vaso-occlusive crises</strong></p></td><td style="vertical-align:top"><p>12.13 &plusmn; 8.56</p></td><td style="vertical-align:top"><p>0.6 &plusmn; 1.37</p></td><td style="vertical-align:top"><p>11.46 &plusmn; 3.01</p></td><td style="vertical-align:top"><p>10.2 &plusmn; 3.24</p></td><td style="vertical-align:top"><p>0.10</p></td><td style="vertical-align:top"><p>&lt;0.001</p></td></tr><tr><td style="vertical-align:top"><p><strong>Blood transfusions</strong></p></td><td style="vertical-align:top"><p>2.43 &plusmn; 0.69</p></td><td style="vertical-align:top"><p>0.13 &plusmn; 0.43</p></td><td style="vertical-align:top"><p>2.13 &plusmn; 0.98</p></td><td style="vertical-align:top"><p>1.98 &plusmn; 0.82</p></td><td style="vertical-align:top"><p>0.25</p></td><td style="vertical-align:top"><p>&lt;0.001</p></td></tr><tr><td style="vertical-align:top"><p><strong>Hospitalisations</strong></p></td><td style="vertical-align:top"><p>10.13 &plusmn; 6.56</p></td><td style="vertical-align:top"><p>0.70 &plusmn; 1.28</p></td><td style="vertical-align:top"><p>9.56 &plusmn; 2.91</p></td><td style="vertical-align:top"><p>9.59 &plusmn; 2.94</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&lt;0.001</p></td></tr></tbody></table><p><em><sup>1.</sup></em><em> P value is for comparison between hydroxycarbamide and placebo groups at baseline</em></p><p><em><sup>2.</sup></em><em> P value is for comparison between hydroxycarbamide and placebo groups at 18 months</em></p><p>&nbsp;</p><p><em>Efficacy and safety in infants (BABY HUG study)</em></p><p>BABY HUG was a phase III double-blinded, multi-centre, randomised, placebo-controlled study in infants aged 9&nbsp;&ndash;&nbsp;18 months. Subjects received oral liquid hydroxycarbamide 20&nbsp;mg/kg/day without escalation, or placebo for two years. Infants were initially monitored every 2 weeks for adverse events and laboratory toxicities until tolerability of the dose was confirmed, then every 4 weeks. Primary study endpoints were splenic function (qualitative uptake on 99mTc spleen scan) and renal function (glomerular filtration rate by 99mTc-DTPA clearance). Additional evaluations included blood counts, HbF, chemistry profiles, spleen function biomarkers, urine osmolality, neurodevelopment, TCD ultrasonography, growth, and mutagenicity. Ninety-six subjects received hydroxycarbamide and 97 placebo; 86% completed the study. Regarding primary endpoints, 19 of 70 patients had decreased spleen function at exit in the hydroxycarbamide group vs 28 of 74 patients in the placebo group and a difference in the mean increase in DTPA glomerular filtration rate in the hydroxycarbamide group versus the placebo group of 2&nbsp;mL/min per 1&middot;73&nbsp;m&sup2;. Regarding secondary endpoints, the following were observed: 177 events of pain in 62 patients in the hydroxycarbamide group vs 375 events in 75 patients in the placebo group and 24 events of dactylitis in 14 patients in the hydroxycarbamide group vs 123 events in 42 patients in the placebo group. Haemoglobin and foetal haemoglobin increased in the hydroxycarbamide group compared to the placebo group, whereas the white blood-cell count decreased. The difference in the endpoints between groups was not statistically significant. Toxicity included mild-to-moderate neutropenia.</p><p><em>&nbsp;</em></p><p><em>Primary stroke prevention (TWiTCH study)</em></p><p>Transcranial Doppler (TCD) with Transfusions Changing to Hydroxycarbamide (TWiTCH) was an NHLBI-funded Phase III multicenter, randomized clinical study comparing 24&nbsp;months of standard treatment (monthly blood transfusions) to alternative treatment (hydroxycarbamide) in 121&nbsp;children aged 4‑16&nbsp;years with Sickle Cell Disease and abnormal TCD velocities (&ge;&nbsp;200&nbsp;cm/s) who had received at least 12&nbsp;months of chronic transfusions and did not have severe vasculopathy, documented clinical stroke, or transient ischaemic attack. The primary objective of this study was to examine if hydroxycarbamide could maintain TCD velocities after an initial period of transfusions as effectively as chronic blood transfusions.</p><p>&nbsp;</p><p>Subjects assigned to standard treatment (n&nbsp;=&nbsp;61) continued to receive monthly blood transfusions to maintain 30%&nbsp;HbS or lower, while those assigned to the alternative treatment (n&nbsp;=&nbsp;60), after having received blood transfusions for a mean duration of 4.5&nbsp;years (&plusmn;2.8), started oral hydroxycarbamide at 20&nbsp;mg/kg/day, which was escalated to each participant&rsquo;s maximum tolerated dose. This study used a non-inferiority study design with a primary endpoint of TCD velocity at 24&nbsp;months, controlling for baseline (enrolment) values. The non-inferiority margin was 15&nbsp;cm/s. At the first scheduled interim analysis, non-inferiority was shown and the sponsor terminated the study. Final model-based TCD velocities were 143&nbsp;cm/s (95%&nbsp;CI&nbsp;140‑146) in children who received standard transfusions and 138&nbsp;cm/s (95%&nbsp;CI&nbsp;135‑142) in those who received hydroxycarbamide, with a difference of 4.54&nbsp;cm/s (95%&nbsp;CI&nbsp;0.10‑8.98). Non-inferiority (p&nbsp;=&nbsp;8.82&times;10<sup>-16</sup>) and post-hoc superiority (p&nbsp;=&nbsp;0.023) were met. There was no difference in life-threatening neurological events between the treatment groups. Iron overload improved more in the hydroxycarbamide than the transfusion arm, with a greater average change in serum ferritin (&ndash;1805&nbsp;versus &ndash;38&nbsp;ng/mL; p&nbsp;&lt;&nbsp;0.0001) and liver iron concentration (average =&nbsp;&ndash;1.9&nbsp;mg/g versus +2.4&nbsp;mg/g dry weight liver; p&nbsp;=&nbsp;0.0011).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Absorption</u></p><p>After oral administration hydroxycarbamide is readily absorbed from the gastrointestinal tract. Peak plasma concentrations are reached within 2&nbsp;hours and by 24&nbsp;hours the serum concentrations are virtually zero. Bioavailability is complete or nearly complete in cancer patients.</p><p>Following oral administration of hydroxycarbamide oral solution in children aged 6 months to 18 years with sickle cell disease, peak plasma concentrations are reached in 0 to 2 hours. Mean peak plasma concentrations and AUCs increase proportionally with increase of dose.</p><p>&nbsp;</p><p>In a comparative bioavailability study in healthy adult volunteers (n&nbsp;=&nbsp;28), 500&nbsp;mg of hydroxycarbamide oral solution was demonstrated to be bioequivalent to the reference 500&nbsp;mg capsule, with respect to both the peak concentration and area under the curve. There was a statistically significant reduction in time to peak concentration with hydroxycarbamide oral solution compared to the reference 500&nbsp;mg capsule (0.5&nbsp;versus 0.75&nbsp;hours, p&nbsp;=&nbsp;0.0467), indicating a faster rate of absorption.</p><p>&nbsp;</p><p>In a study of children with Sickle Cell Disease, liquid and capsule formulations resulted in similar area under the curve, peak concentrations, and half-life. The largest difference in the pharmacokinetic profile was a trend towards a shorter time to peak concentration following ingestion of the liquid compared with the capsule, but that difference did not reach statistical significance (0.74&nbsp;versus 0.97&nbsp;hours, p&nbsp;=&nbsp;0.14).</p><p>&nbsp;</p><p><u>Distribution</u></p><p>Hydroxycarbamide distributes rapidly throughout the human body, enters the cerebrospinal fluid, appears in peritoneal fluid and ascites, and concentrates in leukocytes and erythrocytes. The estimated volume of distribution of hydroxycarbamide approximates total body water. The volume of distribution following oral dosing of hydroxycarbamide is approximately equal to total body water: adult values of 0.48&nbsp;&ndash;&nbsp;0.90&nbsp;L/kg have been reported, whilst in children a population estimate of 0.7&nbsp;L/kg has been reported. The extent of protein binding of hydroxycarbamide is unknown.</p><p>&nbsp;</p><p><u>Biotransformation</u></p><p>It appears that nitroxyl, the corresponding carboxylic acid and nitric oxide are metabolites: Urea has also been shown to be a metabolite of hydroxycarbamide. Hydroxycarbamide at 30, 100 and 300&nbsp;&micro;M is not metabolised in vitro by cytochrome P450s of human liver microsomes. At concentrations ranging from 10 to 300&nbsp;&micro;M, hydroxycarbamide does not stimulate the in vitro ATPase activity of recombinant human P glycoprotein (P-gp), indicating that hydroxycarbamide is not a P-gp substrate. Hence, no interaction is to be expected in case of concomitant administration with substances being substrates of cytochromes P450 or P-gp.</p><p>&nbsp;</p><p><u>Elimination</u></p><p>The total body clearance of hydroxycarbamide in adult patients with Sickle Cell Disease is 0.17&nbsp;L/h/kg.</p><p>The respective value in children was similar, 0.22&nbsp;L/h/kg.</p><p>A significant fraction of hydroxycarbamide is eliminated by nonrenal (mainly hepatic) mechanisms. In adults, the urinary recovery of unchanged drug is reported to be approximately 37% of the oral dose when renal function is normal. In children, the fraction of hydroxycarbamide excreted unchanged into the urine comprised about 50%.</p><p>In adult cancer patients, hydroxycarbamide was eliminated with a half-life of approximately 2-3&nbsp;hours. In children with Sickle Cell Disease, the mean half-life was reported to be 3.9&nbsp;hours.</p><p><u>&nbsp;</u></p><p><u>Elderly</u></p><p>Although there is no evidence of an age effect on the pharmacokinetic-pharmacodynamic relationship, elderly patients may be more sensitive to the effects of hydroxycarbamide and therefore consideration should be given to starting with a lower initial dose and more cautious dose escalation. Close monitoring of blood parameters is advised (see section 4.2).</p><p>&nbsp;</p><p><u>Renal impairment</u></p><p>As renal excretion is a pathway of elimination, consideration should be given to decreasing the dose of hydroxycarbamide in patients with renal impairment. In an open single-dose study in adult patients with Sickle Cell Disease the influence of renal function on pharmacokinetics of hydroxycarbamide was assessed. Patients with normal (CrCl&nbsp;&gt;&nbsp;90 ml/min), mild (CrCl&nbsp;60‑89&nbsp;ml/min), moderate (CrCl&nbsp;30‑&nbsp;59&nbsp;ml/min), severe (CrCl&nbsp;15‑29&nbsp;ml/min) renal impairment, and End Stage Renal Disease (CrCL&nbsp;&lt;&nbsp;15&nbsp;ml/min) received hydroxycarbamide as a single dose of 15&nbsp;mg/kg body weight. In patients, whose CrCl was below 60&nbsp;ml/min or patients with End Stage Renal Disease the mean exposure to hydroxycarbamide was approximately 64% higher than in patients with normal renal function.</p><p>&nbsp;</p><p>It is recommended that the starting dose is reduced by 50% in patients with</p><p>CrCl&nbsp;&lt;&nbsp;60&nbsp;ml/min (see sections 4.2 and 4.3).</p><p>&nbsp;</p><p>Close monitoring of blood parameters is advised in these patients.</p><p>&nbsp;</p><p><u>Hepatic impairment</u></p><p>There are no data that support specific guidance for dose adjustment in patients with hepatic impairment, but, due to safety considerations, hydroxycarbamide is contraindicated in patients with severe hepatic impairment (see section 4.3). Close monitoring of blood parameters is advised in patients with hepatic impairment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Preclinical toxicity studies have demonstrated the most commonly observed effects include bone marrow depression in rats, dogs and monkeys. In some species cardiovascular and haematological effects have also been observed. Observations in monkeys have also shown lymphoid atrophy and degeneration of the small and large intestine. Toxicology studies have also demonstrated testicular atrophy with decreased spermatogenesis and sperm count in rats and decreased testis weight and reduced sperm counts in mice as well. While in dogs reversible spermatogenic arrest was noted.</p><p>&nbsp;</p><p>Hydroxycarbamide is unequivocally genotoxic and although conventional long-term carcinogenicity studies have not been conducted, hydroxycarbamide is presumed to be a transspecies carcinogen which implies a carcinogenic risk to humans.</p><p>&nbsp;</p><p>Hydroxycarbamide crosses the placental barrier, demonstrated by dams exposed to hydroxycarbamide during gestation. Embryotoxicity manifesting as decreased foetal viability, reduced live litter sizes, and developmental delays has been reported in species including mice, hamsters, cats, dogs, and monkeys at doses comparable to human doses. Teratogenic effects manifested as partially ossified cranial bones, absence of eye sockets, hydrocephaly, bipartite sternebrae, and missing lumbar vertebrae.</p><p>&nbsp;</p><p>Hydroxycarbamide administered to male rats at 60&nbsp;mg/kg body weight/day (about double the recommended usual maximum dose in humans) produced testicular atrophy, decreased spermatogenesis and significantly reduced their ability to impregnate females.</p><p>&nbsp;</p><p>Overall, exposure to hydroxycarbamide produces abnormalities in several experimental animal species and affects the reproductive capacity of male and female animals.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Xanthan gum (E415) 4 mg</p><p>Sucralose (E955) 2.5 mg</p><p>Strawberry flavour 0.001 ml</p><p>Methyl parahydroxybenzoate (E218) 0.5 mg</p><p>Sodium hydroxide (E524) Q.S</p><p>Purified water To 1 mL</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years.
After first opening: 12 weeks.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store in a refrigerator (2 &deg;C &ndash; 8 &deg;C).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Amber type III glass bottle with tamper evident child-resistant closure (HDPE with expanded polyethylene liner) containing 150 ml of oral solution.</p><p>Each pack contains one bottle, an <strong>LDPE</strong> bottle adaptor and 2 dosing syringes (a syringe graduated to 3 ml and a syringe graduated <strong>to 10 ml</strong>).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Safe handling</u></p><p>Anyone handling hydroxycarbamide should wash their hands before and after administering a dose. To decrease the risk of exposure, parents and care givers should wear disposable gloves when handling hydroxycarbamide. To minimise air bubbles, the bottle should not be shaken prior to dosing.</p><p>&nbsp;</p><p>Hydroxycarbamide contact with skin or mucous membrane must be avoided. If hydroxycarbamide comes into contact with skin or mucosa, it should be washed immediately and thoroughly with soap and water. Spillages must be wiped immediately.</p><p>&nbsp;</p><p>Women who are pregnant, planning to be or breast-feeding should not handle hydroxycarbamide.</p><p>&nbsp;</p><p>Parents / care givers and patients should be advised to keep hydroxycarbamide out of the sight and reach of children. Accidental ingestion can be lethal for children.</p><p>&nbsp;</p><p>Keep the bottle tightly closed to protect the integrity of the product and minimise the risk of accidental spillage.</p><p>&nbsp;</p><p>Syringes should be rinsed and washed with cold or warm water and dried completely before the next use. Store syringes in a hygienic place with the medicine.</p><p>&nbsp;</p><p><u>Disposal</u></p><p>Hydroxycarbamide is cytotoxic. Any unused product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Nova Laboratories Ireland Limited
3rd Floor
Ulysses House
Foley Street, Dublin 1
D01 W2T2
Ireland

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                March 2025
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>